Close

Amgen (AMGN) Successfully Completes Acquisition Of Five Prime Therapeutics (FPRX)

April 16, 2021 8:29 AM EDT Send to a Friend
Amgen (NASDAQ: AMGN) today announced that it has successfully completed its previously announced tender offer to purchase all outstanding shares ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login